Display Vector Restriction-Site Layout for High-Throughput Binder Transfer

Resolve Bottlenecks,
Find Innovative Solutions
Generate Solutions

Solution Overview

Problem

The conventional process of transferring inserts from display vectors to expression vectors for affinity binder characterization is time-consuming, laborious, and has low throughput with unpredictable efficiency, typically ranging from 50% to 80%.

Innovation Solution

The design of vectors with judiciously engineered restriction enzyme sites and the use of combinations of restriction enzymes and DNA ligases facilitate high-throughput conversion, achieving conversion rates over 90% to 100% by producing compatible sticky ends and religating the nucleic acid sequences in-frame with fusion tags.

Engineering Contradictions & Design Principles

VSEngineering Contradiction Analysis

1Productivity

If conventional subcloning methods are used to transfer inserts from display vectors to expression vectors, then the process can be performed with standard techniques, but the throughput is low and the process is time-consuming and laborious

Engineering Contradiction:
Improvethroughput of insert transferVSAvoidtime required for subcloning
Core Design Contradiction:
ProductivityVSLoss of time

Solution Approach 1:

The vector is segmented into distinct functional regions: a display region containing the surface peptide sequence and a second restriction site, and an expression region containing the fusion tag sequence and first restriction site. This segmentation allows the insert to be selectively transferred from the display vector to the expression vector through restriction enzyme digestion and ligation, dramatically improving throughput by enabling high-throughput automated processing while reducing manual labor compared to conventional subcloning methods

Inventive Principle:
Principle #1Segmentation

Solution Approach 2:

Restriction enzyme sites serve as intermediaries that facilitate the transfer of inserts between display and expression vectors. By incorporating specific restriction sites (first and second restriction sites) at defined locations, the patent enables efficient enzymatic cleavage and subsequent ligation to expression vectors, achieving high conversion rates and throughput while minimizing time and labor requirements

Inventive Principle:
Principle #24Intermediary (Mediator)

2Reliability

If conventional subcloning methods are used to transfer inserts, then standard protocols can be applied, but the efficiency is low and unpredictable, varying from 50% to 80%

Engineering Contradiction:
Improveconversion efficiencyVSAvoidthroughput of binder characterization
Core Design Contradiction:
ReliabilityVSProductivity

Solution Approach 1:

The vector is pre-engineered with specific restriction sites (first and second restriction sites) positioned at optimal locations flanking the insert. This preliminary design ensures that when the vector is subjected to restriction enzyme digestion followed by ligation to expression vectors, the insert transfers with high efficiency and predictability. The pre-planned restriction site architecture eliminates the variability inherent in conventional subcloning, achieving consistent conversion rates above 90% and enabling high-throughput binder characterization

Inventive Principle:
Principle #10Preliminary action

Solution Approach 2:

The patent optimizes specific parameters including the selection of restriction enzyme recognition sequences, the positioning of restriction sites relative to the insert and fusion tag, and the design of compatible sticky ends. These parameter optimizations ensure high-lidelity recombination events during the transfer process, achieving reliable and predictable conversion efficiencies that exceed 90% while maintaining high throughput for affinity binder discovery

Inventive Principle:
Principle #35Parameter changes

3Ease of operation

If inserts are transferred individually or en masse using conventional methods, then the process can be completed, but it is laborious and has low throughput

Engineering Contradiction:
Improvesimplicity of insert transferVSAvoidthroughput of library conversion
Core Design Contradiction:
Ease of operationVSProductivity

Solution Approach 1:

The vector design incorporates universal elements including standardized restriction sites, a通用 fusion tag sequence, and a modular architecture that can accommodate various inserts. This universal design allows the same vector backbone and protocol to be used for transferring diverse inserts from display to expression vectors, greatly simplifying the operation while enabling high-throughput processing of entire libraries simultaneously rather than individual transfers

Inventive Principle:
Principle #6Universality (Multi-functionality)

Applied Scientific Principles

This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.

Function Achieved in This Case

This approach significantly accelerates the affinity binder discovery and characterization processes by enabling high-throughput library screening and binder characterization with enhanced efficiency.

Implementation Method 1

The first and second restriction sites, when cleaved by corresponding restriction endonuclease thereto, produce compatible sticky ends

Methodology Applied
Scientific EffectRestriction enzyme cleavage: Enzyme

Implementation Method 2

employment of combinations of restriction enzymes and DNA ligases to facilitate the conversion

Methodology Applied
Scientific EffectDNA ligation: Enzyme

Data Source

PatentUS12503693B2Integrated system for library construction, affinity binder screening and expression thereof
Publication Date: 2025.12.23 ADAGENE INC
  • US12503693B2 patent drawing
  • US12503693B2 patent drawing
  • US12503693B2 patent drawing

AI summary

A recombinant polynucleotide suitable for use in a display vector is provided. The recombinant polynucleotide includes from 5′ to 3′: a first nucleic acid sequence (or insert) encoding an amino acid sequence to be displayed on a surface; a first pre-selected restriction site; a second nucleic acid sequence encoding a surface peptide capable of being displayed on the surface; and a second pre-selected restriction site. Corresponding display vectors that can be converted into expression vectors in a high-throughput fashion, as well as methods of use thereof, are also provided.